FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Search Results

Dacarbazine Injection
Status: Currently in Shortage
»Date first posted: 10/20/2021
»Therapeutic Categories: Oncology

Expand all

Fresenius Kabi USA, LLC (Revised 04/18/2024)

Company Contact Information:
888-386-1300

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Injection, 10 mg/1 mL (NDC 63323-127-10)	Unavailable	Backordered. Next release May 2024; Check wholesaler inventory	Demand increase for the drug
Injection, 10 mg/1 mL (NDC 63323-128-20)	Unavailable	Backordered. Next release May 2024; Check wholesaler inventory	Demand increase for the drug

Hikma Pharmaceuticals USA, Inc. (Reverified 03/28/2024)

Company Contact Information:
800-631-2174

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Dacarbazine for Injection, USP, Injection, 200 mg per Vial (NDC 0143-9245-10)	Unavailable	Additional lots will be available in the March - April 2024 timeframe. Product will be made available as it is released.	Demand increase for the drug